BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6156842)

  • 1. Predictors of Initial and Sustained Remission in Patients Treated with Antithyroid Drugs for Graves' Hyperthyroidism: The RISG Study.
    Karmisholt J; Andersen SL; Bulow-Pedersen I; Carlé A; Krejbjerg A; Nygaard B
    J Thyroid Res; 2019; 2019():5945178. PubMed ID: 30719273
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic multinodular goiter in a patient with end-stage renal disease and hemodialysis.
    So E; Arakaki R
    Hawaii J Med Public Health; 2014 Jul; 73(7):217-20. PubMed ID: 25089233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
    Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D
    J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between antithyroid effect and serum concentrations of propylthiouracil in patients with hyperthyroidism.
    Kampmann JP; Mølholm Hansen JE
    Br J Clin Pharmacol; 1981 Nov; 12(5):681-6. PubMed ID: 7332734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
    Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of methimazole in human milk.
    Johansen K; Andersen AN; Kampmann JP; Mølholm Hansen JM; Mortensen HB
    Eur J Clin Pharmacol; 1982 Oct; 23(4):339-41. PubMed ID: 6897386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of food intake on presystemic clearance of drugs.
    Melander A; McLean A
    Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of antithyroid drugs.
    Benker G; Reinwein D
    Klin Wochenschr; 1982 Jun; 60(11):531-9. PubMed ID: 6180218
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic properties and bioavailability of methimazole.
    Jansson R; Lindström B; Dahlberg PA
    Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages.
    Messina M; Milani P; Gentile L; Monaco A; Brossa C; Porta M; Camanni F
    J Endocrinol Invest; 1987 Jun; 10(3):291-5. PubMed ID: 3305681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthyroidism. Current drug therapy.
    Stockigt JR; Topliss DJ
    Drugs; 1989 Mar; 37(3):375-81. PubMed ID: 2653792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].
    Nakashima T
    Rinsho Byori; 1982 Feb; 30(2):170-8. PubMed ID: 6177885
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid conversion of carbimazole to methimazole in serum; evidence for an enzymatic mechanism.
    Nakashima T; Taurog A
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):637-48. PubMed ID: 476986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of antithyroid drugs.
    Kampmann JP; Hansen JM
    Clin Pharmacokinet; 1981; 6(6):401-28. PubMed ID: 6172233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
    Lazarus JH; Marchant B; Alexander WD; Clark DH
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 35S-labelled antithyroid drugs in man.
    Alexander WD; Evans V; MacAulay A; Gallagher TF; Londono J
    Br Med J; 1969 May; 2(5652):290-1. PubMed ID: 4180995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.
    Melander A; Hallengren B; Rosendal-Helgesen S; Sjöberg AK; Wählin-Boll E
    Eur J Clin Pharmacol; 1980 Apr; 17(4):295-9. PubMed ID: 6156842
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.